Since there are thousands of stocks listed on the markets, identifying losers and gainers can be one way to see how the market is performing on a particular day. Usually high moves on the market are as a result of some activity conducted by company, some announcements, or media reports. We would like to present you the stocks that are the biggest movers on the market on April 5. Highlights are Innovative Solutions & Support Inc (NASDAQ:ISSC) and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
The top gainer on Friday is Innovative Solutions & Support Inc (NASDAQ:ISSC), which advanced by 30.60% to $7.21 by 2.03 pm EDT. The company is specialized in patents covering technology in the high-res CRT industry and in avionics instrumentation using CRT and LED displays. On Tuesday, Innovative Solutions & Support Inc (NASDAQ:ISSC) announced about signing a contract with Delta Air Lines, under which Delta “will outfit its fleet of 182 MD-88 and MD-90 aircraft as well as several flight simulators with standardized, state-of-the-art glass cockpits and GPS navigation that will improve efficiency, reduce environmental impact and position the fleet to take advantage of procedural improvements outlined in the Federal Aviation Administration’s Next Generation Air Transportation System,” Innovative Solutions said in a statement on its website. The contract’s value is estimated to some $60 million, Marketwatch reported.
Another top gainer on Friday is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) which, however, was the highest gainer in the morning.BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s shares were trading at 29.55% higher at $1.71 by 2.17 pm EDT. The company success on the market which is going on since the beginning of the week, is due to company receiving some good news on the new intravenous drug against flu it is developing currently.
However, it is a bad day for some stocks as well, the top loser on Friday is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), which slid by 36.25% to $4.80 by 2.08 pm EDT. Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. Rigel lost ground on the back of the reports according to which, its licensing partner AstraZeneca plc (ADR) (NYSE:AZN) announced that the first phase 3 study of Fostamatinib (a treatment for rheumatoid arthritis) failed to meet one of the two designed primary endpoints of the trial.
The second “unluckiest” stock on Friday was Radware Ltd. (NASDAQ:RDWR), which develops, manufactures and markets integrated networking solutions. Radware Ltd. (NASDAQ:RDWR)’s shares were trading 22.64% lower by 2.08 pm EDT, after the company has announced that it expects a fall in its first quarter revenue to $45 million, below the company’s guidance of $48.5-49.5 million, Seekingalpha.com reported.
One of the keys for having a productive and successful company is a motivated and inspired team. In 21st century one of the best sources of inspiration represent TED talks. We have compiled for you a list of 20 greatest TED talks of all time.
